Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Animal studies suggest it has a strong safety profile with no toxicity at high doses
Weekly exposure (57 days/week) Weekly Exposure From the 1:1 Pre-blended Vial Daily blend dose 0.5 mg/day Weekly total blend 2.53.5 mg Weekly BPC-157 1.251.75 mg Weekly TB-500 1.251.75 mg Daily blend dose 1.0 mg/day Weekly total blend 5.07.0 mg Weekly BPC-157 2.53.5 mg Weekly TB-500 2.53.5 mg Daily blend dose 1.5 mg/day Weekly total blend 7.510.5 mg Weekly BPC-157 3.755.25 mg Weekly TB-500 3.755.25 mg Daily blend dose 2.0 mg/day Weekly total blend 10.014.0 mg Weekly BPC-157 5.07.0 mg Weekly TB-500 5.07.0 mg Use this to compare a blend schedule against the separate-vial weekly totals in the next tab
Legal limits on BAC, such as the 0.05% limit in Australia, are enforced to ensure individuals remain sober enough to perform tasks without putting themselves or others at risk
Tesamorelin is FDA-approved only for HIV-associated lipodystrophy, ipamorelin is not FDA-approved, and no human trial has tested the two together as a blend
The acne may develop quickly and feel more inflammatory than usual
Protocol compliance: Consistent dosing and proper storage maximize results
US$ 23.67
US$ 29.82
US$ 28.08
US$ 27.52
US$ 24.02
US$ 24.78
US$ 23.98
